Pfizer regains footing - Analysis - 18-01-2018

Pfizer's stock (PFE) jumped higher in the intraday levels, scoring a fresh profit of 1.58% in the last session, or 0.58 points, and attacking the pivotal resistance of 37.39, amid positive pressure from the 50-day SMA, with positive signals from the RSI, while the stock trades within an ascending price channel that guided recent short-term trading. 

Therefore we expect more gains for the stock, especially if the resistance of 37.39 was breached, targeting the next one at 38.21.